Altimmune, Inc. (NASDAQ:ALT) Given Average Recommendation of “Buy” by Analysts
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been given an average rating of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been given an average rating of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on […]
